Physician Photo

Christopher R. Morse, MD

Co-Director Gastroesophageal Surgery Program

Dr Morse is a Associate Visiting Surgeon in the Dept of Surgery and an Assistant Professor of Surgery at Harvard Medical School. He serves as the Co-Director of the Gastroesophageal Surgery Program.

  • Phone: 617-726-2811
Thoracic Surgery
Department of Surgery


  • Cancer Center
  • Thoracic Cancers
  • Thymoma
  • Mesothelioma
  • Esophageal Cancer
  • Lung Cancer
  • Digestive Healthcare Center
  • Swallowing and Heartburn Center
  • Barrett's Esophagus Treatment Center
  • Transplant Center
  • Lung Transplant
Clinical Interests
Esophageal cancer
Minimally invasive esophageal resections (esophagectomy)
Laparoscopic antireflux surgery/GERD
Laparoscopic paraesophageal hernia repair
Laparoscopic re-operative antireflux surgery
Barrett's esophagus
Esophageal cancer, Barrett's esophagus
Esophageal disease
Esophageal anomalies
Lung cancer
Minimally invasive pulmonary (lung) resections
Airway surgery
Thoracic surgery
Benign and malignant diseases of the chest
Idiopathic Laryngotracheal Stenosis
Boston: Massachusetts General Hospital
Lowell: Lowell General Hospital
Salem: North Shore Medical Center
Medical Education
MD, Columbia University College of Physicians and Surgeons
Residency, Massachusetts General Hospital
Board Certifications
Surgery, American Board of Surgery
Thoracic Surgery, American Board of Thoracic Surgery
Patient Age Group
Accepting New Patients
Accepting New Patients

BiographyDr Morse graduated from Columbia University College of Physicians and Surgeons. He did both his surgical residencies at the MGH, first in general surgery and then in Cardiothoracic Surgery. Dr. Morse went on complete a second fellowship in minimally invasive thoracic surgery with a particular emphasis on esophageal surgery. He is Board certified in both Surgery and Thoracic Surgery.

Dr Morse is clinically very active and sees new patients weekly. His clinical interests revolve around malignancies of the chest, especially lung and esophageal cancer, as well as the treatment a variety of benign esophageal conditions, including achalasia, paraesophageal hernia and gastroesophageal reflux disease. Dr. Morse has taken a lead role in the development of a minimally invasive esophagectomy program at MGH. This work has led to a number of manuscripts including a direct comparison of open vs. minimally invasive esophagectomy.

Dr. Morse serves as the co-director of the MGH Gastroesophageal Surgery program and participates on workforces in several national thoracic societies.


My research is primarily related to outcomes of the diseases I treat. I am especially focused on esophageal cancer and participate in an international esophagectomy complications consensus group. I have published extensively on minimally invasive esophageal resections. I was also recently the editor of a textbook, Master Techniques in Surgery: Thoracic Surgery, describing detailed techniques of thoracic surgery with an international group of authors.


View my most recent publications at PubMed

Recent Publications

  1. Tapias-Vargas LF, Morse CR. Minimally Invasive Ivor Lewis Esophagectomy after Induction Therapy Yields Similar Early Outcomes to Surgery Alone. Innovations. 2011 Sep;6(5):331-6
  2. Tapias-Vargas LF, Morse CR. A Preliminary Experience with Minimally Invasive Ivor Lewis Esophagectomy. Dis Esophagus. 2012 Jul;25(5):449-55.
  3. Sihag S, Wright CD, Wain JC, Lanuti M, Gaissert HA, Donahue DA, Mathisen DJ, Morse CR. Comparison of Perioperative Outcomes Following Open vs Minimally Invasive Ivor Lewis Esophagectomy at  Single High-Volume Center. Eur J Cardiothorac Surg 2012 Sep;42(3):430-7.
  4. Tapias-Vargas LF, Morse CR. Minimally invasive Ivor Lewis Esophagectomy: Description of a learning curve. Journal of the American College of Surgeons. 2014 Jun; 218(6):1130-40.

Preview clip of Digestive Healthcare Center CME program

Christopher Morse, MD, reviews minimally invasive treatments for esophageal cancer, including esophageal resections. Please note that this video contains images from a real procedure and may cause discomfort for some viewers.

Minimally Invasive Esophagectomy (MIE)

Minimally invasive esophagectomy (MIE) is a procedure performed by Massachusetts General Hospital surgeons using small incisions to remove a diseased esophagus and reconstruct the gastrointestinal tract. For more information, visit

Minimally invasive surgery lessens pain of esophageal cancer

Christopher Morse, MD, of the Division of Thoracic Surgery at Massachusetts General Hospital has been able to remove esophageal tumors using an innovative minimally invasive procedure that offers patients less postoperative pain and a shorter recovery time

Getting Back to Active: Bob’s Story

Bob Hazelton lived with chronic acid reflux for years and was diagnosed with esophageal cancer in 2011. After his surgical team at Massachusetts General Hospital performed a minimally invasive esophagectomy, Bob has a healthy esophagus and is getting back to his active lifestyle.

Division of Thoracic Surgery
55 Fruit Street
Boston, MA 02114-2696

Phone: 617-726-2811
Fax: 617-726-7667